Disfiguring annular sarcoidosis improved by adalimumab

Case Reports in Dermatology

Volumn 3, Issue 2, 2011, Pages 103-106

  Kaiser, C A ^a   Cozzio, A ^a   Hofbauer, G F L ^a   Kamarashev, J ^a   French, L E ^a   Navarini, A A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adalimumab; Cutaneous sarcoidosis; Sarcoidosis treatment; Systemic sarcoidosis; TNF antagonist

Indexed keywords

ADALIMUMAB; CARBON MONOXIDE; CHLOROQUINE; ETRETIN; ISOTRETINOIN; METHOTREXATE; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANNULAR SARCOIDOSIS; ARTICLE; CASE REPORT; DERMATOLOGY LIFE QUALITY INDEX; DISEASE ACTIVITY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FOREHEAD; GRANULOMA; HILAR ADENOPATHY; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG DISEASE; LUNG FUNCTION TEST; LUNG HILUS; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE INDEX; REMISSION; SARCOIDOSIS; SCALP; SCAR; SIDE EFFECT; SKIN BIOPSY; TREATMENT DURATION; TRUNK; VISUAL ANALOG SCALE;

EID: 80052698838     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000328796     Document Type: Article

References (5)

1. Heffernan MP, Anadkat MJ: Recalcitrant cutaneous sarcoidosis responding to infliximab. Arch Dermatol 2005;141:910-911. (Pubitemid 41058083)
2. Amiri P, Locksley RM, Parslow TG, et al: Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992;356:604-607.
3. Antoniu SA: Targeting the TNF-alpha pathway in sarcoidosis. Expert Opin Ther Targets 2010;14:21-29.
4. Cohen JD, Bournerias I, Buffard V, et al: Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol 2007;34:380-385.
5. Gifre L, Ruiz-Esquide V, Xaubet A, Gomez-Puerta JA, Hernandez MV, Sanmarti R: Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review (in Spanish). Arch Bronconeumol 2011;47:208-212.